🔎 Trials Near Me

መነሻ › ዋና የድንጋጠ መዳከም ችግር › አርካንሳስ

በአርካንሳስ ለዋና የድንጋጠ መዳከም ችግር የሚደረጉ ክሊኒካዊ ጥናቶች

ለዋና የድንጋጠ መዳከም ችግር የሚደረጉ 15 ጥናቶች በአርካንሳስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በአርካንሳስ ውስጥ ያሉ ከተሞች

Official study text (English)

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

  • SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06559306

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  • Vanda Investigational Site, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06830044

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07105111

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Pillar Clinical Research, Bentonville
  • SanRo Clinical Research Group, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bentonville
  • Draig Clinical Site, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT06911112

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  • Preferred Research Partners, Inc., Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07592689

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Woodland International Research Group, Little Rock
  • Woodland Research Northwest, Rogers
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
  • Neurocrine Clinical Site, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

  • Preferred Research Partners /ID# 279206, Little Rock
  • Woodland International Research Group /ID# 277605, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Pillar Clinical Research, LLC, Little Rock
  • Preferred Research Partners, Inc., Little Rock
  • Woodland Research Northwest, Rogers
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሜይ 2026 · NCT06524830

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኦክቶ 2025 · NCT06786624

Study of ALTO-300 in MDD

  • Site 193, Rogers
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2025 · NCT05922878

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።